Novo Nordisk says consumer group wrong about Victoza (Reuters, 20 April 2012)

Control faulty gene to protect weak bones (Futurity, 19 April 2012)

EU agency endorses Bristol, Astra diabetes drug (Reuters, 20 April 2012)

23 Apr 2012

The European Medicines Agency has recommended approval of new type 2 diabetes drug dapagliflozin (Forxiga).

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read